Finally, BO-pf treatment significantly upregulated the expression of the anti-inflammatory cytokines with protective activity, namely IL-10 and TGFβ, thus suggesting a potential role for BO-pf in the treatment and/or prevention of IBD. Here, TGFB1 is linked to inflammatory bowel disease.